GPATCH3
Basic information
Region (hg38): 1:26890488-26900467
Previous symbols: [ "GPATC3" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the GPATCH3 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 3 | |||||
missense | 35 | 37 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 0 | |||||
Total | 0 | 0 | 35 | 5 | 0 |
Variants in GPATCH3
This is a list of pathogenic ClinVar variants found in the GPATCH3 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
1-26891119-G-A | not specified | Uncertain significance (Jun 05, 2023) | ||
1-26891164-C-T | Uncertain significance (May 25, 2017) | |||
1-26891202-T-C | GPATCH3-related disorder | Likely benign (May 03, 2019) | ||
1-26891208-T-C | GPATCH3-related disorder | Likely benign (Mar 28, 2019) | ||
1-26892705-C-T | not specified | Uncertain significance (Oct 04, 2022) | ||
1-26892752-C-T | not specified | Uncertain significance (Dec 28, 2022) | ||
1-26892755-A-G | not specified | Uncertain significance (Jul 12, 2023) | ||
1-26892777-C-T | not specified | Uncertain significance (Aug 02, 2021) | ||
1-26892786-C-T | not specified | Uncertain significance (Apr 08, 2024) | ||
1-26893439-T-C | not specified | Uncertain significance (Jan 25, 2023) | ||
1-26894262-G-A | not specified | Uncertain significance (May 29, 2024) | ||
1-26894343-C-T | not specified | Uncertain significance (Mar 29, 2022) | ||
1-26894353-C-T | not specified | Likely benign (Apr 12, 2023) | ||
1-26894359-C-T | not specified | Uncertain significance (Dec 20, 2022) | ||
1-26894390-T-A | not specified | Uncertain significance (Nov 07, 2022) | ||
1-26894400-C-A | not specified | Uncertain significance (May 03, 2023) | ||
1-26894401-G-C | not specified | Uncertain significance (Dec 28, 2023) | ||
1-26897317-T-A | not specified | Uncertain significance (Jun 18, 2021) | ||
1-26897395-T-A | not specified | Uncertain significance (Jan 23, 2023) | ||
1-26897402-T-C | not specified | Uncertain significance (Mar 01, 2023) | ||
1-26897417-C-T | not specified | Uncertain significance (Mar 11, 2022) | ||
1-26897476-T-C | GPATCH3-related disorder | Likely benign (Jul 16, 2019) | ||
1-26897480-C-G | not specified | Uncertain significance (Aug 15, 2023) | ||
1-26897537-G-A | not specified | Uncertain significance (Nov 20, 2023) | ||
1-26897539-G-C | not specified | Uncertain significance (Jan 30, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
GPATCH3 | protein_coding | protein_coding | ENST00000361720 | 7 | 9979 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
6.40e-14 | 0.0595 | 125532 | 0 | 216 | 125748 | 0.000859 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.226 | 327 | 316 | 1.04 | 0.0000183 | 3379 |
Missense in Polyphen | 119 | 115.44 | 1.0308 | 1191 | ||
Synonymous | -0.213 | 127 | 124 | 1.02 | 0.00000626 | 1099 |
Loss of Function | 0.534 | 22 | 24.9 | 0.885 | 0.00000125 | 267 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000593 | 0.000593 |
Ashkenazi Jewish | 0.000599 | 0.000595 |
East Asian | 0.000109 | 0.000109 |
Finnish | 0.000925 | 0.000832 |
European (Non-Finnish) | 0.00127 | 0.00126 |
Middle Eastern | 0.000109 | 0.000109 |
South Asian | 0.000817 | 0.000817 |
Other | 0.000981 | 0.000978 |
dbNSFP
Source:
- Function
- FUNCTION: Involved in transcriptional regulation. It is able to activate transcription from the CXCR4 promoter and therefore it might control neural crest cell migration involved in ocular and craniofacial development (PubMed:28397860). Is a negative regulator of immune antiviral response, acting via down-regulation of RIG-I-like receptors signaling and inhibition of type I interferon production. The control mechanism involves interaction with mitochondrial MAVS and inhibition of MAVS assembly with downstream proteins implicated in antiviral response, such as TBK1 and TRAF6 (PubMed:28414768). {ECO:0000269|PubMed:28397860, ECO:0000269|PubMed:28414768}.;
Intolerance Scores
- loftool
- 0.924
- rvis_EVS
- -0.55
- rvis_percentile_EVS
- 19.8
Haploinsufficiency Scores
- pHI
- 0.0540
- hipred
- N
- hipred_score
- 0.167
- ghis
- 0.523
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.931
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Gpatch3
- Phenotype
Zebrafish Information Network
- Gene name
- gpatch3
- Affected structure
- iridophore
- Phenotype tag
- abnormal
- Phenotype quality
- decreased amount
Gene ontology
- Biological process
- negative regulation of type I interferon production;negative regulation of RIG-I signaling pathway;positive regulation of transcription, DNA-templated
- Cellular component
- nucleus;cytoplasm
- Molecular function
- nucleic acid binding;protein binding